000			01735 a2200493 4500
005			20250516202232.0
264		0	_c20150124
008			201501s 0 0 eng d
022			_a1743-1328
024	7		_a10.1179/1743132813Y.0000000293 _2doi
040			_aNLM _beng _cNLM
100	1		_aAnastácio, Janine R
245	0	0	_aResveratrol treatment has neuroprotective effects and prevents cognitive impairment after chronic cerebral hypoperfusion. _h[electronic resource]
260			_bNeurological research _cJul 2014
300			_a627-33 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBrain Ischemia _xdrug therapy
650	0	4	_aCell Count
650	0	4	_aCognition Disorders _xprevention & control
650	0	4	_aHippocampus _xdrug effects
650	0	4	_aMale
650	0	4	_aMaze Learning _xdrug effects
650	0	4	_aMemory, Short-Term _xdrug effects
650	0	4	_aNerve Growth Factor _xmetabolism
650	0	4	_aNeurons _xdrug effects
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aNeuropsychological Tests
650	0	4	_aRandom Allocation
650	0	4	_aRats, Wistar
650	0	4	_aResveratrol
650	0	4	_aSpatial Memory _xdrug effects
650	0	4	_aStilbenes _xpharmacology
700	1		_aNetto, Carlos A
700	1		_aCastro, Cibele C
700	1		_aSanches, Eduardo F
700	1		_aFerreira, Daniele C
700	1		_aNoschang, Cristie
700	1		_aKrolow, Rachel
700	1		_aDalmaz, Carla
700	1		_aPagnussat, Aline
773	0		_tNeurological research _gvol. 36 _gno. 7 _gp. 627-33
856	4	0	_uhttps://doi.org/10.1179/1743132813Y.0000000293 _zAvailable from publisher's website
999			_c23632378 _d23632378